Follow-up for cancer is changing! We argue that follow-up should be patient-, not calendar-driven, and focus on late effects, not recurrence. Read our editorial in @actaoncol#survivorship#lateeffects@senfoelger
https://t.co/6Fx43pJHqO
Måske dagens vigtigste spørgsmål fra Lena Saltbæk på seminar om senfølger @Senfoelger@DCCCcancer Hvem har ansvaret for hvad på senfølgeområdet? Hvornår peger pilen på det basale eller specialiserede niveau, på det offentlige eller indsatser hos fx @cancer_dk?
Exciting presentation by @KettiMazzocco at #IPOS2022 about the Bounce project investigating a large(!) array of psychosocial predictors of psychological adaptation to breast cancer. Looking forward to results to inform which modifiable risk factors to target in women at high risk
Lonnekke van de Poll-Franse @lvdpollfranse
gave an inspiring plenary on using PRO to tailor survivorship care, not only to those at greatest need, but maybe also to find those fro whom care intensity can be reduced. Food for thought and future work! #IPOS2022
@ToniLindsayPsyc shared insight on dealing with the ever-present challenge of uncertainty in cancer treatment and survivorship in this morning's pre-congress workshop. Such an important topic - great kick off to #IPOS2022@CASTLE_research@Senfoelger
Snart afholdes ECRS 2022 - et symposium om livet med kræft for klinikere, forskere og administratorer - som @CASTLE_research arrangerer med forskere fra Kræftens Bekæmpelses Forskningscenter, støttet af @actaoncol. I kan stadig tilmelde jer! @Senfoelger https://t.co/q6Yb7VYlAf